Guidant Completes Enrollment in Int'l Drug Eluting Stent Clinical Trial
10th Nov 2005, 19:51 GMT
Guidant Corp announced that the company has completed enrollment in its SPIRIT II drug eluting stent clinical trial.
Latest news from Angiography/ Cardiac Cath News from StratCenter.com:
- Thinking Systems Releases Enhanced PET-CT Functions for Its ThinkingPACS
- Tallahassee Memorial Hospital at the Forefront in Treatment of Heart Attack Patients
- Preliminary Long-Term Clinical Data Show Promising Results for the CYPHER Sirolimus-eluting Coronary Stent in Patients With Multi-Vessel Disease